Cargando…

“The invisible”: Participant's experiences in clinical trials

BACKGROUND: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. METHODOLOGY: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadimpally, Sarojini, Bhagianadh, Divya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299806/
https://www.ncbi.nlm.nih.gov/pubmed/28194331
http://dx.doi.org/10.4103/2229-3485.198550
_version_ 1782506098123603968
author Nadimpally, Sarojini
Bhagianadh, Divya
author_facet Nadimpally, Sarojini
Bhagianadh, Divya
author_sort Nadimpally, Sarojini
collection PubMed
description BACKGROUND: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. METHODOLOGY: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra and Andhra Pradesh. In addition to CT participants, other key informants including investigators, representatives of Contract Research Organizations (CROs), sponsor, Ethics Committee (EC) members etc. were also interviewed to develop a comprehensive understanding of the functioning of the CT sector. FINDINGS AND DISCUSSION: The paper describes the perspectives of participants on the relevant aspects of recruitment into CTs, reasons for participation in CTs, informed consent, adverse events and compensation. The role played by the push and pull factors in recruitment, the information asymmetry, the power imbalance between the health-care provider and seeker, the role of sociocultural factors, etc., are explored in the paper. Combined with the insights from other stakeholders, the study gives an understanding about the chasm between regulations and realities in the Indian CT sector. Further, the paper briefly explores the recent changes and amendments in the laws governing the CT sector that is aimed at improving the conduct of CTs and uphold the rights of participants. CONCLUSION: Participants are the most important stakeholders in a CT setting. It is imperative that their voices are heard and their rights upheld for the ethical conduct of CTs.
format Online
Article
Text
id pubmed-5299806
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-52998062017-02-13 “The invisible”: Participant's experiences in clinical trials Nadimpally, Sarojini Bhagianadh, Divya Perspect Clin Res Original Article BACKGROUND: The paper discussing the perspectives of clinical trial participants about the various aspects of CTs is based on the primary research conducted by Sama in 2012-13. METHODOLOGY: In-depth interviews were conducted with 36 CT participants from the states of New Delhi, Gujarat, Maharashtra and Andhra Pradesh. In addition to CT participants, other key informants including investigators, representatives of Contract Research Organizations (CROs), sponsor, Ethics Committee (EC) members etc. were also interviewed to develop a comprehensive understanding of the functioning of the CT sector. FINDINGS AND DISCUSSION: The paper describes the perspectives of participants on the relevant aspects of recruitment into CTs, reasons for participation in CTs, informed consent, adverse events and compensation. The role played by the push and pull factors in recruitment, the information asymmetry, the power imbalance between the health-care provider and seeker, the role of sociocultural factors, etc., are explored in the paper. Combined with the insights from other stakeholders, the study gives an understanding about the chasm between regulations and realities in the Indian CT sector. Further, the paper briefly explores the recent changes and amendments in the laws governing the CT sector that is aimed at improving the conduct of CTs and uphold the rights of participants. CONCLUSION: Participants are the most important stakeholders in a CT setting. It is imperative that their voices are heard and their rights upheld for the ethical conduct of CTs. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5299806/ /pubmed/28194331 http://dx.doi.org/10.4103/2229-3485.198550 Text en Copyright: © 2017 Perspectives in Clinical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Nadimpally, Sarojini
Bhagianadh, Divya
“The invisible”: Participant's experiences in clinical trials
title “The invisible”: Participant's experiences in clinical trials
title_full “The invisible”: Participant's experiences in clinical trials
title_fullStr “The invisible”: Participant's experiences in clinical trials
title_full_unstemmed “The invisible”: Participant's experiences in clinical trials
title_short “The invisible”: Participant's experiences in clinical trials
title_sort “the invisible”: participant's experiences in clinical trials
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299806/
https://www.ncbi.nlm.nih.gov/pubmed/28194331
http://dx.doi.org/10.4103/2229-3485.198550
work_keys_str_mv AT nadimpallysarojini theinvisibleparticipantsexperiencesinclinicaltrials
AT bhagianadhdivya theinvisibleparticipantsexperiencesinclinicaltrials